Department of Orthopaedics and Rehabilitation, University of Rochester, 601 Elmwood Ave, Box 665, Rochester, NY, USA.
World J Surg. 2023 Jan;47(1):40-49. doi: 10.1007/s00268-022-06767-8. Epub 2022 Oct 6.
Current literature describing the riskiness of operating on actively infected COVID-19 patients far outnumbers that on the risk of operating on recovered patients. The purpose of this study was to analyze a single, tertiary referral center experience regarding postoperative complications and readmissions in COVID-19-recovered patients versus COVID-19-naïve (never previously infected) patients undergoing elective and emergency surgery across all surgical subspecialties.
All PCR positive COVID-19 patients that underwent a surgical procedure between February 1, 2020, and November 1, 2020, were included in the COVID-positive cohort. These patients were then matched to COVID-naïve controls that underwent similar procedures within the same time frame. Primary outcomes included 30-day postoperative complications as well as 90-day readmissions. Multivariable analyses were also performed.
112 COVID-positive patients met inclusion criteria and were all matched to COVID-naïve controls. 76 patients (68%) underwent surgery > 30 days from their COVID diagnosis. COVID-positive patients were at significantly higher risk of 30-day complications compared to the COVID-naïve cohort (22% versus 8%, respectively; p < 0.01). Multivariable analyses found ambulatory/asymptomatic infections, undergoing surgery between 30 and 120 days from diagnosis, initial presentation to the emergency department and elevated ASA scores to be significantly associated with 30-day complications. No differences were found for 90-day readmissions.
Patients with previous COVID-19 infections carry a higher perioperative risk profile for 30-day complications compared to COVID-naïve counterparts in unvaccinated populations.
目前描述在活跃感染 COVID-19 的患者身上进行手术的风险的文献数量远远超过描述在已康复的患者身上进行手术的风险。本研究的目的是分析一家三级转诊中心在所有外科亚专业领域中,对 COVID-19 康复患者与 COVID-19 未感染(从未感染过)患者接受择期和急诊手术的术后并发症和再入院率的单一经验。
所有在 2020 年 2 月 1 日至 2020 年 11 月 1 日期间进行过手术且 PCR 阳性的 COVID-19 患者均被纳入 COVID-19 阳性组。然后,将这些患者与在同一时间段内接受类似手术的 COVID-19 未感染对照患者进行匹配。主要结果包括 30 天术后并发症和 90 天再入院。还进行了多变量分析。
112 名符合纳入标准的 COVID-19 阳性患者均与 COVID-19 未感染对照患者相匹配。76 名患者(68%)在 COVID 诊断后 30 天以上接受手术。COVID-19 阳性患者的 30 天并发症风险明显高于 COVID-19 未感染患者(分别为 22%和 8%,p<0.01)。多变量分析发现,门诊/无症状感染、在诊断后 30 至 120 天进行手术、最初在急诊就诊和升高的 ASA 评分与 30 天并发症显著相关。未发现 90 天再入院率存在差异。
与未接种疫苗的人群中 COVID-19 未感染的对照患者相比,既往感染过 COVID-19 的患者在围手术期 30 天并发症的风险特征更高。